Page last updated: 2024-12-10

24-hydroxyvitamin d3

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

24-hydroxyvitamin D3: RN given refers to (3beta,5Z,7E,24R)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5283729
MeSH IDM0096943

Synonyms (8)

Synonym
24-hydroxyvitamin d3
(24r)-24-hydroxyvitamin d3 / (24r)-24-hydroxycholecalciferol
(5z,7e)-(3s,24r)-9,10-seco-5,7,10(19)-cholestatriene-3,24-diol
LMST03020244
56720-87-7
9,10-secocholesta-5,7,10(19)-triene-3,24-diol, (3beta,5z,7e,24r)-
24(r)-hydroxyvitamin d3
24(r)-hydroxycholecalciferol

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" In the calcium-supplemented healthy subjects, the pharmacokinetic quantities were not significantly different while the area under the serum concentration-time curve and the estimated bioavailability were significantly decreased."( Human pharmacokinetics of orally administered (24 R)-hydroxycalcidiol.
Barto, R; Greuter, H; Leeuwenkamp, OR; Lips, P; Netelenbos, JC; van der Vijgh, WJ; van der Wiel, HE, 1993
)
0.29

Bioavailability

ExcerptReferenceRelevance
" In the calcium-supplemented healthy subjects, the pharmacokinetic quantities were not significantly different while the area under the serum concentration-time curve and the estimated bioavailability were significantly decreased."( Human pharmacokinetics of orally administered (24 R)-hydroxycalcidiol.
Barto, R; Greuter, H; Leeuwenkamp, OR; Lips, P; Netelenbos, JC; van der Vijgh, WJ; van der Wiel, HE, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (37.50)18.7374
1990's2 (25.00)18.2507
2000's1 (12.50)29.6817
2010's1 (12.50)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.23 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.69 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]